Your session is about to expire
← Back to Search
Behavioral Intervention
PROVIDENT for Opioid Overdose (PROVIDENT Trial)
N/A
Waitlist Available
Led By Brandon DL Marshall, PhD
Research Sponsored by Brown University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
- Cities and towns in Rhode Island
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline up to 2.5 years following intervention, with assessment of primary outcome at 2.5 years
Awards & highlights
PROVIDENT Trial Summary
This trial will help to predict and prevent future overdose outbreaks by identifying which communities are most at risk and implementing targeted prevention programs.
Who is the study for?
This trial is for cities and towns in Rhode Island to test a new way of predicting opioid overdose outbreaks. There are no specific exclusion criteria, meaning all areas within the state can participate.Check my eligibility
What is being tested?
The study is testing PROVIDENT, an opioid overdose forecasting tool designed to predict future overdose events and help target prevention programs effectively to neighborhoods at highest risk.See study design
What are the potential side effects?
Since this intervention involves data analysis and resource allocation rather than direct medical treatment, there are no traditional side effects associated with it.
PROVIDENT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPROVIDENT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline up to 2.5 years following intervention, with assessment of primary outcome at 2.5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline up to 2.5 years following intervention, with assessment of primary outcome at 2.5 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in accidental fatal and non-fatal drug overdoses
PROVIDENT Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Within these cities/towns, the health department will work with stakeholders to prioritize overdose prevention interventions to neighborhoods with the highest probability of future overdose deaths, as predicted by the PROVIDENT model.
Group II: ControlActive Control1 Intervention
Cities/towns assigned to the control arm will continue to work with the health department and distribute these interventions at existing resource levels, but without receiving information on predicted probability of overdose risk for specific neighborhoods.
Find a Location
Who is running the clinical trial?
Brown UniversityLead Sponsor
454 Previous Clinical Trials
562,726 Total Patients Enrolled
2 Trials studying Drug Overdose
602 Patients Enrolled for Drug Overdose
New York UniversityOTHER
226 Previous Clinical Trials
314,216 Total Patients Enrolled
1 Trials studying Drug Overdose
600 Patients Enrolled for Drug Overdose
National Institute on Drug Abuse (NIDA)NIH
2,459 Previous Clinical Trials
2,597,257 Total Patients Enrolled
20 Trials studying Drug Overdose
6,709 Patients Enrolled for Drug Overdose
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there currently availability to enroll in this clinical trial?
"In accordance with clinicaltrials.gov, the latest edition of this medical trial was uploaded on December 1st 2021 and it is not presently recruiting patients. However, there are 14 separate trials that have active recruitment processes at present."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger